Your Article Summary
The p38 MAPK regulates 11-beta-hydroxysteroid dehydrogenase type 2 (11-beta-HSD2) expression in human trophoblast cells through modulation of 11-beta-HSD2 mRNA stability
Endocrinology, 06/10/09
Sharma A et al. - The findings suggest a novel pathway controlling placental 11-beta-HSD2 expression resulting from the activation of p38 MAPK. Given that p38-alpha is abundantly expressed in the human placenta where its function is largely unknown, the present study also reveals 11-beta-HSD2 as an important target through which p38-alpha may regulate human placental function, and consequently fetal growth and development.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Metabolic reprogramming, caloric restriction and aging
Trends in Endocrinology and Metabolism, 12/14/09
miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer
Clinical Cancer Research, 12/14/09
Growth Hormone (GH) Deficiency Type II: A Novel GH-1 Gene Mutation (GH-R178H) Affecting Secretion and Action
Journal of Clinical Endocrinology and Metabolism, 12/11/09
Today in Fetal Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Recent advances in our understanding of protein and amino acid metabolism in the human fetus
Current Opinion in Clinical Nutrition & Metabolic Care, 12/14/09
Sex and the Human Placenta: Mediating Differential Strategies of Fetal Growth and Survival
Placenta, 12/14/09
Using Z-scores to compare biometry data obtained during prenatal ultrasound screening by midwives and physicians
Prenatal Diagnosis, 12/11/09

See Latest Articles